BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18671896)

  • 1. Neuronal nitric oxide synthase expression in glial tumors: correlation with malignancy and tumor proliferation.
    Tanriover N; Ulu MO; Isler C; Durak H; Oz B; Uzan M; Akar Z
    Neurol Res; 2008 Nov; 30(9):940-4. PubMed ID: 18671896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
    Erdamar S; Bagci P; Oz B; Dirican A
    J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors.
    Iwata S; Nakagawa K; Harada H; Oka Y; Kumon Y; Sakaki S
    Neurosurgery; 1999 Jul; 45(1):24-8; discussion 29. PubMed ID: 10414562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 immunoreactivity, basic fibroblastic growth factor (bFGF) expression, and microvessel density as supplementary prognostic tools in low-grade astrocytomas. An immunohistochemical study with special reference to the reliability of different Ki-67 antibodies.
    Torp SH; Alsaker M
    Pathol Res Pract; 2002; 198(4):261-5. PubMed ID: 12049334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cyclin A and cyclin B1 proteins in astrocytomas.
    Allan K; Jordan RC; Ang LC; Taylor M; Young B
    Arch Pathol Lab Med; 2000 Feb; 124(2):216-20. PubMed ID: 10656729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.
    Kim CH; Bak KH; Kim YS; Kim JM; Ko Y; Oh SJ; Kim KM; Hong EK
    Surg Neurol; 2000 Sep; 54(3):235-40. PubMed ID: 11118570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in human brain tumors: relationships of iNOS to superoxide dismutase (SOD) proteins (SOD1 and SOD2), Ki-67 antigen (MIB-1) and p53 protein.
    Kato S; Esumi H; Hirano A; Kato M; Asayama K; Ohama E
    Acta Neuropathol; 2003 Apr; 105(4):333-40. PubMed ID: 12624786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
    Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
    J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nitric oxide synthase in neuroepithelial brain tumors].
    Sosunov AA; Chairkin IN; Odyvanova LR; Guski G; Tservos-Navarro DZh
    Arkh Patol; 1997; 59(6):61-5. PubMed ID: 9483223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase expression of oligodendrogliomas.
    Broholm H; Braendstrup O; Lauritzen M
    Clin Neuropathol; 2001; 20(6):233-8. PubMed ID: 11758777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide synthase expression and enzymatic activity in human brain tumors.
    Broholm H; Rubin I; Kruse A; Braendstrup O; Schmidt K; Skriver EB; Lauritzen M
    Clin Neuropathol; 2003; 22(6):273-81. PubMed ID: 14672505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas.
    Wang M; Tang J; Liu S; Yoshida D; Teramoto A
    J Neurooncol; 2005 Jan; 71(1):3-7. PubMed ID: 15719267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. J1-31 protein expression in astrocytes and astrocytomas.
    Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
    Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal and inducible nitric oxide synthase expression in the rat cerebellum following portacaval anastomosis.
    Suárez I; Bodega G; Rubio M; Felipo V; Fernández B
    Brain Res; 2005 Jun; 1047(2):205-13. PubMed ID: 15904901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors.
    Khalid H; Shibata S; Kishikawa M; Yasunaga A; Iseki M; Hiura T
    Cancer; 1997 Dec; 80(11):2133-40. PubMed ID: 9392336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
    Hara A; Okayasu I
    Acta Neuropathol; 2004 Jul; 108(1):43-8. PubMed ID: 15088099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
    Thotakura M; Tirumalasetti N; Krishna R
    J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.